Association between psoriasis and chronic obstructive pulmonary disease: A population-based study in Taiwan

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 1, 2012, Pages 59-65

  Chiang, Y Y ^a   Lin, H W ^b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; RISK; SURVIVAL; TAIWAN;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PSORIASIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TAIWAN;

EID: 83755225180     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04009.x     Document Type: Article

References (56)

1. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
2. Schon MP, Boehncke WH,. Psoriasis. N Engl J Med 2005; 352: 1899-1912. (Pubitemid 40627816)
3. Langley RG, Krueger GG, Griffiths CE,. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64 (Suppl. 2): ii18-23; discussion ii24-15. (Pubitemid 40288514)
4. Chandran V, Raychaudhuri SP,. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010; 34: J314-321.
5. Chang YT, Chen TJ, Liu PC, et al. Epidemiological study of psoriasis in the national health insurance database in Taiwan. Acta Derm Venereol 2009; 89: 262-266.
6. Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M,. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 2010; 37: 146-155.
7. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM,. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-835. (Pubitemid 44556851)
8. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73. (Pubitemid 46934281)
9. Dreiher J, Weitzman D, Davidovici B, Shapiro J, Cohen AD,. Psoriasis and dyslipidaemia: a population-based study. Acta Derm Venereol 2008; 88: 561-565.
10. Cohen AD, Weitzman D, Dreiher J,. Psoriasis and hypertension: a case-control study. Acta Derm Venereol 2010; 90: 23-26.
11. Dreiher J, Weitzman D, Cohen AD,. Psoriasis and osteoporosis: a sex-specific association? J Invest Dermatol 2009; 129: 1643-1649.
12. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
13. Cosio MG, Saetta M, Agusti A,. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360: 2445-2454.
14. Sethi S, Murphy TF,. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 2355-2365.
15. Chung KF, Adcock IM,. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008; 31: 1334-1356.
16. Tiengo A, Fadini GP, Avogaro A,. The metabolic syndrome, diabetes and lung dysfunction. Diabetes Metab 2008; 34: 447-454.
17. Fabbri LM, Luppi F, Beghe B, Rabe KF,. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31: 204-212.
18. Watz H, Waschki B, Kirsten A, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009; 136: 1039-1046.
19. Tan WC, Seale P, Ip M, et al. Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific. Respirology 2009; 14: 90-97.
20. Pearce DJ, Morrison AE, Higgins KB, et al. The comorbid state of psoriasis patients in a university dermatology practice. J Dermatolog Treat 2005; 16: 319-323. (Pubitemid 43170202)
21. Dreiher J, Weitzman D, Shapiro J, Davidovici B, Cohen AD,. Psoriasis and chronic obstructive pulmonary disease: a case-control study. Br J Dermatol 2008; 159: 956-960.
22. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M,. Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol 2007; 57: 963-971. (Pubitemid 350087343)
23. Zachariae R, Zachariae H, Blomqvist K, et al. Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol 2004; 18: 27-36. (Pubitemid 38159357)
24. Jankovic S, Raznatovic M, Marinkovic J, Jankovic J, Maksimovic N,. Risk factors for psoriasis: a case-control study. J Dermatol 2009; 36: 328-334.
25. He Z, Chen Y, Chen P, Wu G, Cai S,. Local inflammation occurs before systemic inflammation in patients with COPD. Respirology 2010; 15: 478-484.
26. Spah F,. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol 2008; 159 (Suppl. 2): 10-17.
27. Takahashi H, Takahashi I, Honma M, Ishida-Yamamoto A, Iizuka H,. Prevalence of metabolic syndrome in Japanese psoriasis patients. J Dermatol Sci 2010; 57: 143-144.
28. Paek YJ, Jung KS, Hwang YI, Lee KS, Lee DR, Lee JU,. Association between low pulmonary function and metabolic risk factors in Korean adults: the Korean National Health and Nutrition Survey. Metabolism 2010; 59: 1300-1306.
29. Miele L, Vallone S, Cefalo C, et al. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol 2009; 51: 778-786.
30. Makredes M, Robinson D Jr, Bala M, Kimball AB,. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J Am Acad Dermatol 2009; 61: 405-410.
31. Coimbra S, Oliveira H, Reis F, et al. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol 2010; 24: 789-796.
32. Poole CD, Conway P, Currie CJ,. An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice. Rheumatology (Oxford) 2009; 48: 78-82.
33. Eckel RH, Grundy SM, Zimmet PZ,. The metabolic syndrome. Lancet 2005; 365: 1415-1428. (Pubitemid 40523737)
34. Poulain M, Doucet M, Drapeau V, et al. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chron Respir Dis 2008; 5: 35-41. (Pubitemid 351903614)
35. Johnston A, Arnadottir S, Gudjonsson JE, et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol 2008; 159: 342-350. (Pubitemid 352009847)
36. Sethi S, Maloney J, Grove L, Wrona C, Berenson CS,. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 991-998.
37. Tsoumakidou M, Tzanakis N, Siafakas NM,. Induced sputum in the investigation of airway inflammation of COPD. Respir Med 2003; 97: 863-871. (Pubitemid 36944116)
38. Huang SL, Su CH, Chang SC,. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 1436-1439.
39. Sapey E, Wood AM, Ahmad A, Stockley RA,. TNF{alpha} rs361525 polymorphism is associated with increased local production and downstream inflammation in COPD. Am J Respir Crit Care Med 2010; 182: 192-199.
40. Zhan P, Wang J, Wei SZ, et al. TNF-308 gene polymorphism is associated with COPD risk among Asians: meta-analysis of data for 6,118 subjects. Mol Biol Rep 2011; 38: 219-227.
41. Balding J, Kane D, Livingstone W, et al. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum 2003; 48: 1408-1413. (Pubitemid 36554540)
42. Rennard SI, Fogarty C, Kelsen S, et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 926-934. (Pubitemid 46684703)
43. Suissa S, Ernst P, Hudson M,. TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2008; 21: 234-238.
44. Krueger JG, Bowcock A,. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64 (Suppl. 2): ii30-36. (Pubitemid 40288517)
45. Van Pottelberge GR, Bracke KR, Joos GF, Brusselle GG,. The role of dendritic cells in the pathogenesis of COPD: liaison officers in the front line. COPD 2009; 6: 284-290.
46. Morhenn VB,. Langerhans cells may trigger the psoriatic disease process via production of nitric oxide. Immunol Today 1997; 18: 433-436. (Pubitemid 27381985)
47. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K,. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 2000; 162: 701-706. (Pubitemid 30647222)
48. Naldi L, Mercuri SR,. Smoking and psoriasis: from epidemiology to pathomechanisms. J Invest Dermatol 2009; 129: 2741-2743.
49. Braathen LR, Botten G, Bjerkedal T,. Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venereol Suppl (Stockh) 1989; 142: 9-12. (Pubitemid 19163997)
50. Gerdes S, Zahl VA, Weichenthal M, Mrowietz U,. Smoking and alcohol intake in severely affected patients with psoriasis in Germany. Dermatology 2010; 220: 38-43.
51. Tanni SE, Pelegrino NR, Angeleli AY, Correa C, Godoy I,. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J Inflamm (Lond) 2010; 7: 29.
52. Ito K, Barnes PJ,. COPD as a disease of accelerated lung aging. Chest 2009; 135: 173-180.
53. Huang YH, Yang LC, Hui RY, et al. Relationships between obesity and the clinical severity of psoriasis in Taiwan. J Eur Acad Dermatol Venereol 2010; 24: 1035-1039.
54. Sood A,. Obesity, adipokines, and lung disease. J Appl Physiol 2010; 108: 744-753.
55. Nijsten T, Wakkee M,. Complexity of the association between psoriasis and comorbidities. J Invest Dermatol 2009; 129: 1601-1603.
56. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ,. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141: 1537-1541. (Pubitemid 41815843)